Browse Related Topics For:

Hatch-Waxman

67
Patents
44
Generic Drugs
40
Pharmaceutical
36
Pharmaceutical Patents
31
ANDA
28
Patent Infringement
26
FTC
26
Patent Litigation
25
FDA
24
Pharmaceutical Manufacturers
23
SCOTUS
22
Reverse Payment Settlement Agreements
20
FTC v Actavis
20
Prescription Drugs
13
Pay-For-Delay
11
Antitrust Litigation
10
Settlement
8
Anti-Competitive
7
Actavis Inc.
7
Biosimilars
7
BPCIA
7
Patent Trial and Appeal Board
6
Drug Manufacturers
6
Inter Partes Review Proceedings
6
Mylan Pharmaceuticals
6
Safe Harbors
5
Cephalon
5
Infringement
5
Personal Jurisdiction
5
Popular
5
Teva Pharmaceuticals
4
America Invents Act
4
AstraZeneca
4
Declaratory Judgments
4
FDCA
4
Obviousness
4
Patent Reform
3
Apotex
3
Biologics
3
Claim Construction
3
Classen Immunotherapies
3
DaimlerChrysler v Bauman
3
Prior Art
3
Standard of Review
3
Unfair Competition
3
Watson Pharmaceuticals
2
Antitrust Provisions
2
Appeals
2
Biotechnology
2
Burden of Proof
2
CA Supreme Court
2
Cartwright Act
2
Corporate Counsel
2
Damages
2
De Novo Standard of Review
2
Disgorgement
2
Doctrine of Equivalents
2
Elan Pharmaceuticals
2
Generic
2
GlaxoSmithKline
2
Intellectual Property Litigation
2
Jurisdiction
2
Manufacturers
2
Merck
2
Non-Practicing Entities
2
Preemption
2
Preliminary Injunctions
2
Presumption of Validity
2
Product Hopping
2
Reverse Payments
2
Rule-of-Reason Analysis
2
Sandoz v Amgen
2
Subject Matter Jurisdiction
2
Teva v Sandoz
1
Allergan Inc
1
Amgen
1
AMP v Myriad
1
Annual Reports
1
Article III
1
Biofuel
1
Biogen Idec
1
Biologics Price Competition and Innovation Act of 2009
1
Biopharmaceutical
1
Bowman v Monsanto
1
Brand
1
Burden-Shifting
1
Certiorari
1
Cipro
1
Claim Preclusion
1
Class Action
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
Coca Cola
1
Combination Products
1
Competition
1
Consent Order
1
Consideration
1
Covered Business Method Proceedings
1
Crestor
1
DaimlerAG
1
Design Defects
1
Design Patent
1
Discovery
1
Discovery Schedule
1
Dismissals
1
DNA
1
Drug Approvals
1
Duty to Deal
1
eBay
1
Eli Lilly
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
Exemptions
1
Expert Testimony
1
Extrinsic Evidence
1
Failure To Warn
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
Forum
1
Forum Shopping
1
Fresenius
1
Genzyme
1
Hedge Funds
1
Human Genes
1
Injunctions
1
Innovation Act
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Inventions
1
Jazz Pharmaceuticals
1
Joinder
1
Justiciable Controversy
1
Labeling
1
Lanham Act
1
Life Sciences
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Mayo v. Prometheus
1
Medical Devices
1
Medicare Modernization Act
1
Minimum Contacts
1
Misrepresentation
1
Monopolization
1
Monsanto
1
Motion to Dismiss
1
Mutual Pharmaceuticals v Bartlett
1
Myriad
1
Noninfringement
1
Novartis
1
Orange Book
1
Otsuka Pharmaceutical
1
Par Pharmaceutical
1
Par/Paddock
1
Patent Applications
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Trolls
1
Patent-Eligible Subject Matter
1
Patent-in-Suit
1
Patentability Search
1
Pfizer
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Premarket Approval Applications
1
Price Manipulation
1
Prioritized Examination
1
Product Exclusivity
1
Proposed Amendments
1
Proposed Regulation
1
Regulatory Agenda
1
Reissue Patents
1
Restraint of Trade
1
Reversal
1
Ripeness
1
Rosuvastatin
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sandoz
1
Scope of the Patent Test
1
Sherman Act
1
Standard of Proof
1
Standing
1
Supplemental Examination
1
Takeda Pharmaceuticals
1
The Consumer Relief Fund
1
USPTO
1
Vaccinations
1
Validity
1
Valuation
1
Vitiation Test
1
Written Descriptions